Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Lens Eye Toxic Res. 1990;7(3-4):311-8.

Pravastatin--ocular side effects after a two year follow-up?

Author information

  • 1Department of Ophthalmology, University of Goettingen, FRG.

Abstract

Pravastatin, a new HMG-CoA-reductase inhibitor, was administered to hypercholesterolemic 14 patients with coronary heart disease for a period of two years. This drug reduces the plasma LDL-cholesterol concentrations approximately 30-40%. No development of cataracts or other ocular side effects could be observed during this two year follow-up.

PMID:
2129219
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk